News

Framingham State's Entrepreneur Innovation Center gives local startups access to resources and support to help grow their ...
Sanofi’s innovation hub, which employs 2,500 people, is based in Cambridge, Massachusetts. Swiftwater, Pennsylvania contains the company’s vaccine production sites, whilst Framingham ...
Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.
When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.
HealthDay News — The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ...
The FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice regulations for active pharmaceutical ingredients.
FDA has issued a warning letter to Sanofi summarizing “significant deviations” from current good manufacturing practice (CGMP) for APIs based on inspections conducted from June 12 to July 9, 2024, at ...
Despite receiving a prior wrist slap from the FDA last summer, Sanofi has yet to right the ship at its drug ingredients plant in Massachusetts.
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts.
Framingham Public Schools was awarded a grant of $159,617 in funding to help further life science education.